Navigation Links
MMJ BioScience Moving Forward with Cannabis Multiple Sclerosis FDA Study
Date:8/27/2017

MMJ International Holding’s, the premier medical cannabis research company that is advancing the science of medical marijuana through patient clinical research and the operation of medical cannabis healthcare businesses, today announced that it's affiliate MMJ Bioscience has engaged Bianca Weinstock-Guttman, MD, as their principal investigator.

Dr. Bianca Weinstock-Guttman is a Professor of Neurology at the State University of New York at Buffalo and serves as Executive Director of the New York State Multiple Sclerosis Consortium. She will execute the FDA approved study exploring the potential therapeutic applications of cannabinoids for progressive multiple sclerosis patients. MMJ BioScience's will be providing new evidence regarding clinical outcomes leading to commercial success in the scientific process of MMJ BioScience’s first pharmaceutical cannabidiol (CBD) derived medicine.

A large percentage of Multiple Sclerosis patients are resistant to currently available treatments and experience symptoms including spasticity and pain. These conditions are difficult to manage and treatment options are currently limited. The day-to-day impact of these devastating conditions are significant and with high rates of mortality, there is a considerable unmet patient need for MMJ BioScience’s novel new drug.

Tom Ryan, MMJ’s COO stated that, “MMJ BioScience’s discovery of a novel cannabinoid pharmacology through our network of world leading scientists, our intellectual property portfolio, proprietary formulations, contract processing, and regulatory expertise uniquely position us to develop and manufacture plant-derived cannabinoid formulations at sufficient quality and uniformity according to the FDA regulatory requirements for pharmaceutical development.”

"Our initiation of the Phase 2 clinical trial programs and the eventual FDA Fast Track Designation for Progressive Multiple Sclerosis signify important steps forward in MMJ BioScience's ongoing commitment to investigating innovative scientific approaches with the hope of bringing new treatment options to patients," stated Tom Ryan.

According to the FDA, Fast Track Designation is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need In the U.S. The FDA Orphan Drug Designation is granted to medicines and biologics that are defined as those intended for the safe and effective treatment, diagnosis, or prevention of rare diseases or disorders that affect fewer than 200,000 people in the U.S.

While a growing number of states have legalized marijuana for medical use, medical marijuana differs from pharmaceutical treatments in that even state to state legal forms are not FDA regulated. For this reason, there is no way to ensure consistency between batches or even that there is accurate product labeling.

In addition, there is no standardization in terms of how these products are prescribed or dosed for specific conditions. The MMJ BioScience team will be carefully conducting these controlled studies to determine the benefits and risks of medical marijuana products for safe patient use.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14637320.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. CNA Finance Provides Research Update On Aytu Bioscience And Natesto®
2. Tosoh Bioscience LLC Announces Partnership with PolyAnalytik Inc.
3. CNA Finance Initiates Research Coverage On Aytu Bioscience
4. Caprion Biosciences Expands Biomarker Panel Portfolio to Include Predictive Tuberculosis (TB) Infections
5. ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug
6. ACEA Biosciences Announces Collaboration with Memorial Sloan Kettering Cancer Center on Personalized CAR T Cell Therapy
7. Vortex Biosciences Announces Publication in Nature Precision Oncology Describing the Genomic and Phenotypic Characterization of CTCs from Prostate Cancer Patients
8. Therapix Biosciences Announces the Appointment of Josh Blacher as Chief Financial Officer
9. ACEA Biosciences Introduces a Multi-Option Configuration NovoCyte® Flow Cytometer
10. Pendant Biosciences Announces Acceptance into JLABS @ Toronto
11. Roka Bioscience to participate in the 40th Annual National Food Policy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... ... May 19, 2020 , ... Experienced periodontist in Eden Prairie, MN, Dr. ... bone grafting through PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations to gently cut ... a patient for dental implants, especially when the implants need to be placed in ...
(Date:5/21/2020)... ... May 20, 2020 , ... Exo (pronounced “Echo”) ... the company’s executive vice president of product engineering and report directly to CEO ... imaging space, bringing more than 24 years of technology leadership experience from Google, ...
(Date:5/15/2020)... Mass. (PRWEB) , ... May 14, 2020 , ... ... but to undergo multiple open heart surgeries before becoming adults. The ... , To address this critical unmet need, the Department of Defense has ...
(Date:5/15/2020)... ... ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, ... continue to lead Sentien’s Board of Directors, a role he has filled for the ... management team. , Mr. Ganz has more than 30 years of experience ...
Breaking Biology Technology:
(Date:6/23/2020)... ... ... The field of quantitation of large molecules or proteins has been around ... the use of mass spectrometry in this field has gained a lot of momentum ... choose which approach to use (LBA or MS)?” In many cases, either technology ...
(Date:6/23/2020)... ... ... In its June 22 online post, business and technology news platform Superb Crew reported ... director of stem cell biotechnology company Asymmetrex . Superb Crew decided to highlight ... it would begin offering free tissue stem cell counting at its company ...
(Date:6/19/2020)... SAN DIEGO (PRWEB) , ... ... ... host a three-part webinar series, “Automate Your Lab with Software for Data ... engineers. Attendees will learn how to integrate and automate cutting-edge scientific instruments ...
Breaking Biology News(10 mins):